Acanthosis

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 5280 Experts worldwide ranked by ideXlab platform

Wenjun Ouyang - One of the best experts on this subject based on the ideXlab platform.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Patricia A Valdez, Ian Kasman, Jeffrey Easthamanderson, Jianfeng Wu, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels1. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (TH17 cells)2,3, was found to have a potential function in the pathogenesis of psoriasis4,5. Here we show that IL-22 is preferentially produced by TH17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from TH17 cells is differentially regulated. Transforming growth factor-β, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that TH17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Ian Kasman, Jeffrey Easthamanderson, Patricia Valdez, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (T(H)17 cells), was found to have a potential function in the pathogenesis of psoriasis. Here we show that IL-22 is preferentially produced by T(H)17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from T(H)17 cells is differentially regulated. Transforming growth factor-beta, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that T(H)17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

Yan Zheng - One of the best experts on this subject based on the ideXlab platform.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Patricia A Valdez, Ian Kasman, Jeffrey Easthamanderson, Jianfeng Wu, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels1. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (TH17 cells)2,3, was found to have a potential function in the pathogenesis of psoriasis4,5. Here we show that IL-22 is preferentially produced by TH17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from TH17 cells is differentially regulated. Transforming growth factor-β, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that TH17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Ian Kasman, Jeffrey Easthamanderson, Patricia Valdez, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (T(H)17 cells), was found to have a potential function in the pathogenesis of psoriasis. Here we show that IL-22 is preferentially produced by T(H)17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from T(H)17 cells is differentially regulated. Transforming growth factor-beta, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that T(H)17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

Jeffrey Easthamanderson - One of the best experts on this subject based on the ideXlab platform.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Patricia A Valdez, Ian Kasman, Jeffrey Easthamanderson, Jianfeng Wu, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels1. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (TH17 cells)2,3, was found to have a potential function in the pathogenesis of psoriasis4,5. Here we show that IL-22 is preferentially produced by TH17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from TH17 cells is differentially regulated. Transforming growth factor-β, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that TH17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Ian Kasman, Jeffrey Easthamanderson, Patricia Valdez, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (T(H)17 cells), was found to have a potential function in the pathogenesis of psoriasis. Here we show that IL-22 is preferentially produced by T(H)17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from T(H)17 cells is differentially regulated. Transforming growth factor-beta, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that T(H)17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

Ian Kasman - One of the best experts on this subject based on the ideXlab platform.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Patricia A Valdez, Ian Kasman, Jeffrey Easthamanderson, Jianfeng Wu, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels1. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (TH17 cells)2,3, was found to have a potential function in the pathogenesis of psoriasis4,5. Here we show that IL-22 is preferentially produced by TH17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from TH17 cells is differentially regulated. Transforming growth factor-β, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that TH17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Ian Kasman, Jeffrey Easthamanderson, Patricia Valdez, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (T(H)17 cells), was found to have a potential function in the pathogenesis of psoriasis. Here we show that IL-22 is preferentially produced by T(H)17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from T(H)17 cells is differentially regulated. Transforming growth factor-beta, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that T(H)17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

Dimitry M Danilenko - One of the best experts on this subject based on the ideXlab platform.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Patricia A Valdez, Ian Kasman, Jeffrey Easthamanderson, Jianfeng Wu, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels1. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (TH17 cells)2,3, was found to have a potential function in the pathogenesis of psoriasis4,5. Here we show that IL-22 is preferentially produced by TH17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from TH17 cells is differentially regulated. Transforming growth factor-β, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that TH17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.

  • interleukin 22 a t h 17 cytokine mediates il 23 induced dermal inflammation and Acanthosis
    Nature, 2007
    Co-Authors: Yan Zheng, Dimitry M Danilenko, Ian Kasman, Jeffrey Easthamanderson, Patricia Valdez, Wenjun Ouyang
    Abstract:

    Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis (Acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels. The underlying cause of the epidermal Acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (T(H)17 cells), was found to have a potential function in the pathogenesis of psoriasis. Here we show that IL-22 is preferentially produced by T(H)17 cells and mediates the Acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from T(H)17 cells is differentially regulated. Transforming growth factor-beta, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced Acanthosis and dermal inflammation through the activation of Stat3 (signal transduction and activators of transcription 3) in vivo. Our results suggest that T(H)17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.